UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.15 +0.20 (+0.25%) GOLD FUTURES
2,314.30 +4.70 (+0.20%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,333.84 +1,193.06 (+2.59%)
Sangamo Therapeutics, Inc. (SGMO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.5438 |
| Open | 0.5700 |
| Bid | 0.5163 x 400 |
| Ask | 0.5905 x 100 |
| Day's range | 0.5150 - 0.5700 |
| 52-week range | 0.2900 - 1.6700 |
| Volume | |
| Avg. volume | 2,423,940 |
| Market cap | 108.313M |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4800 |
| Earnings date | 02 May 2024 - 04 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.50 |
Business WireSangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
RICHMOND, Calif., May 02, 2024--Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
Business WireSangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
RICHMOND, Calif., April 22, 2024--Sangamo Therapeutics to Present Neurology Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at ASGCT
Simply Wall St.What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today
One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic...
© 2024 Yahoo. All rights reserved.